Clinical Trials Browser

Phase 1/2 × Small Cell Lung Carcinoma × Penfluridol × Clear all

NCT07206563 2025-10-03

Penfluridol for Relapsed/Refractory Small Cell Cancers

Phase 1/2 Not yet recruiting

Recurrence, Carcinoma, Small Cell, Small Cell Lung Carcinoma